Joseph J. Wolk - Feb 10, 2023 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
Exec VP, CFO
Signature
Raavi K. Deol, as attorney-in-fact for Joseph J. Wolk
Stock symbol
JNJ
Transactions as of
Feb 10, 2023
Transactions value $
-$158,676
Form type
4
Date filed
2/14/2023, 03:36 PM
Previous filing
Dec 15, 2022
Next filing
Feb 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $0 +3.45K +9.63% $0.00 39.3K Feb 10, 2023 Direct F1
transaction JNJ Common Stock Tax liability -$159K -979 -2.49% $162.08 38.3K Feb 10, 2023 Direct F2
holding JNJ Common Stock 1.99K Feb 10, 2023 By 401k F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Restricted Share Units Options Exercise $0 -3.45K -100% $0.00* 0 Feb 10, 2023 Common Stock 3.45K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.
F2 Shares withheld for payment of taxes upon vesting of Restricted Share Units.
F3 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2023).